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To the editor,
There have been more than 40,000 reported cases of
coronavirus disease (COVID-19) in Brazil until May 8, 2020.
Recurrent testing among health care professionals is the key
step to be undertaken by hospitals, as completely asympto-
matic infection might occur among these professionals.
Hospital das Clinicas is the main hospital dedicated to
COVID-19 response in the city of Sao Paulo, with 224
intensive care unit beds.
We have set up a PCR testing program to detect COVID-19
among symptomatic health care professionals in the early
phase of the epidemic. However, an antibody-based screen-
ing program was difficult to establish because of the lack
of available antibody tests in Brazil. Recently, we received
a donation of Wondfo One Step COVID-19 rapid test kits
(Guangzhou, China) from a Brazilian company. The test is
generally performed on capillary blood samples, but it can
also be performed on peripheral blood, plasma, and serum.
We collected 47 paired samples (capillary and serum)
from health care workers within 15 days of their confir-
med diagnosis of COVID-19 by PCR to validate the test.
The results were compared with those of the Euroimmun
IgG EIA test (Luebeck, Germany).
The results of the test have been summarized in Table 1.
The rapid test showed a low sensitivity when performed
with capillary blood (55%); however, when tested on serum
samples it exhibited a similar sensitivity to that of the
Euroimmun IgG EIA assay (96%).
Recently, the government of Brazil has purchased a
considerable number of Wondfo rapid test kits. Our results
indicate that this test should not be performed using capil-
lary blood but rather be performed with plasma or serum.
Table 1 - Comparison of the Wondfo One Step COVID-19 test
(capillary and serum samples) and Euroimmun IgG EIA test results.
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